These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24280226)

  • 1. Prion infection impairs cholesterol metabolism in neuronal cells.
    Cui HL; Guo B; Scicluna B; Coleman BM; Lawson VA; Ellett L; Meikle PJ; Bukrinsky M; Mukhamedova N; Sviridov D; Hill AF
    J Biol Chem; 2014 Jan; 289(2):789-802. PubMed ID: 24280226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
    Kumar R; McClain D; Young R; Carlson GA
    J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.
    Gilch S; Bach C; Lutzny G; Vorberg I; Schätzl HM
    Cell Mol Life Sci; 2009 Dec; 66(24):3979-91. PubMed ID: 19823766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.
    Cui HL; Grant A; Mukhamedova N; Pushkarsky T; Jennelle L; Dubrovsky L; Gaus K; Fitzgerald ML; Sviridov D; Bukrinsky M
    J Lipid Res; 2012 Apr; 53(4):696-708. PubMed ID: 22262807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol and its reciprocal association with prion infection.
    Cashion J; Zhang W; Ali T; Gilch S
    Cell Tissue Res; 2023 Apr; 392(1):235-246. PubMed ID: 35821439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.
    Ditiatkovski M; Mukhamedova N; Dragoljevic D; Hoang A; Low H; Pushkarsky T; Fu Y; Carmichael I; Hill AF; Murphy AJ; Bukrinsky M; Sviridov D
    J Biol Chem; 2020 Sep; 295(38):13377-13392. PubMed ID: 32732283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of small GTPase Rab7 activation in prion infection negatively affects a feedback loop regulating neuronal cholesterol metabolism.
    Cherry P; Lu L; Shim SY; Ebacher V; Tahir W; Schatzl HM; Hannaoui S; Gilch S
    J Biol Chem; 2023 Feb; 299(2):102883. PubMed ID: 36623732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein accumulation in lipid rafts of mouse aging brain.
    Agostini F; Dotti CG; Pérez-Cañamás A; Ledesma MD; Benetti F; Legname G
    PLoS One; 2013; 8(9):e74244. PubMed ID: 24040215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
    Stewart RS; Piccardo P; Ghetti B; Harris DA
    J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.
    Yamasaki T; Baron GS; Suzuki A; Hasebe R; Horiuchi M
    Virology; 2014 Feb; 450-451():324-35. PubMed ID: 24503096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of antisera to purified prions in lipid rafts.
    Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
    Prion; 2010; 4(2):94-104. PubMed ID: 20647769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
    Bate C; Salmona M; Diomede L; Williams A
    J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
    Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
    Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.